
| ANOVA | |||||
| 实验结果 | |||||
| Sum of Squares | df | Mean Square | F | Sig. | |
| Between Groups | 43.194 | 3 | 14.398 | 13.697 | .000 |
| Within Groups | 37.842 | 36 | 1.051 | ||
| Total | 81.036 | 39 | |||
| Multiple Comparisons | ||||||
| Dependent Variable: 实验结果 | ||||||
| Dunnett t (2-sided)a | ||||||
| (I) 分组 | (J) 分组 | Mean Difference (I-J) | Std. Error | Sig. | 95% Confidence Interval | |
| Lower Bound | Upper Bound | |||||
| 0.5 | 对照组 | -2.15000* | .45851 | .000 | -3.2743 | -1.0257 |
| 1.0 | 对照组 | -2.27000* | .45851 | .000 | -3.3943 | -1.1457 |
| 1.5 | 对照组 | -2.66000* | .45851 | .000 | -3.7843 | -1.5357 |
PA=0.000113 PB=0.000051 PC=0.000004均小于0.001
根据完全随机资料的方差分析,按α=0.05水准,拒绝H0,接受H1,认为四组治疗组小白鼠的肿瘤重量总体均数不全相等,即不同剂量药物注射液的抑癌作用有差别。
3.
| Tests of Between-Subjects Effects | ||||||
| Dependent Variable: 重量 | ||||||
| Source | Type III Sum of Squares | df | Mean Square | F | Sig. | |
| Hypothesis | 99736.333 | 1 | 99736.333 | 58.4 | .005 | |
| Error | 5115.667 | 3 | 1705.222a | |||
| 治疗 | Hypothesis | 6503.167 | 2 | 3251.583 | 44.867 | .000 |
| Error | 434.833 | 6 | 72.472b | |||
| 分组 | Hypothesis | 5115.667 | 3 | 1705.222 | 23.529 | .001 |
| Error | 434.833 | 6 | 72.472b | |||
P:0.000246 0.001020<0.01
根据随机区组资料的方差分析,按α=0.05水准,拒绝H0,接受H1,三组注射不同剂量雌激素的大白鼠子宫重量总体均数不全相等,即注射不同剂量的雌激素对大白鼠子宫重量有影响
5.
| Tests of Between-Subjects Effects | ||||||
| Dependent Variable: 脉搏次数 | ||||||
| Source | Type III Sum of Squares | df | Mean Square | F | Sig. | |
| Hypothesis | 348005.606 | 1 | 348005.606 | 436.868 | .000 | |
| Error | 3845.883 | 4.828 | 796.592a | |||
| 防护服 | Hypothesis | 218.026 | 4 | 54.506 | 1.243 | .344 |
| Error | 526.141 | 12 | 43.845b | |||
| 受试者 | Hypothesis | 2853.674 | 4 | 713.418 | 16.271 | .000 |
| Error | 526.141 | 12 | 43.845b | |||
| 试验日期 | Hypothesis | 508.074 | 4 | 127.018 | 2.7 | .068 |
| Error | 526.141 | 12 | 43.845b | |||
P:0.344 0.000086 0.068
根据拉丁方设计资料的方差分析,0.344>0.05,按α=0.05水准,接受H0,拒接H1,认为穿五种防护服时的脉搏数总体均数相等,即尚不能认为五种防护服对脉搏数有不同影响。
6.
| Tests of Between-Subjects Effects | ||||||
| Dependent Variable: PEF | ||||||
| Source | Type III Sum of Squares | df | Mean Square | F | Sig. | |
| Hypothesis | 2525259.375 | 1 | 2525259.375 | 462.279 | .000 | |
| Error | 46080.7 | 8.436 | 5462.633a | |||
| 治疗 | Hypothesis | 7526.042 | 1 | 7526.042 | 8.454 | .016 |
| Error | 02.083 | 10 | 0.208b | |||
| 受试者 | Hypothesis | 67303.125 | 11 | 6118.466 | 6.873 | .002 |
| Error | 02.083 | 10 | 0.208b | |||
| 阶段 | Hypothesis | 234.375 | 1 | 234.375 | .263 | .619 |
| Error | 02.083 | 10 | 0.208b | |||
P:0.016 0.00248 0.619
根据双阶段交叉设计资料的方差分析,由以上结果,按α=0.05标准,①0.016<0.05,认为不同药物之间差别有统计学意义,即A和B两种药的测定结果有差别;②0.002<0.05,可认为不同患者之间差别有统计学意义,即各哮喘儿童服药5小时后的PEF值不同;③0.619>0.05,无统计学意义,即还不能认为测定阶段对测定结果有影响。
